These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9833910)

  • 21. Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.
    De Maria N; Colantoni A; Rosenbloom E; Van Thiel DH
    Hepatogastroenterology; 1996; 43(12):1472-9. PubMed ID: 8975951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Severe Hypercholesterolemia in a Woman With Advanced Primary Sclerosing Cholangitis.
    Xiao C; Hegele RA; Lewis GF
    JAMA Cardiol; 2017 May; 2(5):575-576. PubMed ID: 28384790
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].
    Christensen KL; Andersen BN; Vilstrup H
    Ugeskr Laeger; 1997 Nov; 159(48):7151-3. PubMed ID: 9417723
    [TBL] [Abstract][Full Text] [Related]  

  • 26.  Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.
    Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH
    Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Lindor KD; Kowdley KV; Harrison ME;
    Am J Gastroenterol; 2015 May; 110(5):646-59; quiz 660. PubMed ID: 25869391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V; Lammert F
    EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
    [No Abstract]   [Full Text] [Related]  

  • 30. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
    Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
    Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Hay JE; Malinchoc M; Dickson ER
    J Hepatol; 2001 Feb; 34(2):292-8. PubMed ID: 11281559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
    Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
    Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
    Chapman RW
    Dig Liver Dis; 2003 May; 35(5):306-8. PubMed ID: 12846401
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: A Pediatric Case.
    Fujita Y; Sugaya T; Inui A; Yoshihara S
    Tohoku J Exp Med; 2021 Feb; 253(2):109-112. PubMed ID: 33551380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for primary sclerosing cholangitis.
    Sinakos E; Lindor K
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation.
    Boner AL; Peroni D; Bodini A; Delaini G; Piacentini G
    Int J Immunopathol Pharmacol; 2007; 20(4):847-9. PubMed ID: 18179759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sclerosing cholangitis as a complication of Langerhans'cell histiocytosis].
    Pagnoux C; Hayem G; Roux F; Palazzo E; Meyer O
    Rev Med Interne; 2003 May; 24(5):324-7. PubMed ID: 12763179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
    Olsson R; Boberg KM; de Muckadell OS; Lindgren S; Hultcrantz R; Folvik G; Bell H; Gangsøy-Kristiansen M; Matre J; Rydning A; Wikman O; Danielsson A; Sandberg-Gertzén H; Ung KA; Eriksson A; Lööf L; Prytz H; Marschall HU; Broomé U
    Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.